Le Lézard
Classified in: Science and technology

Transplant LIMS Software Company, HLA Data Systems, Expands Leadership Team with New CEO


HOUSTON, Nov. 14, 2018 /PRNewswire-PRWeb/ -- HLA Data Systems, a provider of software solutions to HLA Laboratories and health systems, announced today the hiring of a new Chief Executive Officer. Michael Joseph Reardon, Ph.D., brings a wealth of both scientific knowledge and practical expertise to the leadership team. Michael has a Ph.D. in genetics from Boston College, and spent the last 7 years assisting lab professionals with their complex genetic testing needs. He has significant experience leading support and marketing teams, driving sales, and coordinating software development efforts. In his previous role as Technical Consultant for One Lambda/TDX and Linkage Biosciences, he spent 3 years working directly with the histocompatibility and immunogenetics community.

Michael joins a growing team of software executives, laboratory managers, and business professionals who have been providing solutions to the transplantation community for the last 20 years. "Our passion for innovation and customer success drives us to provide intuitive, elegant software solutions to the complex needs of laboratories."

 

SOURCE HLA Data Systems


These press releases may also interest you

at 06:16
Autoliv, Inc. , the worldwide leader in automotive safety systems, today announced that as of March 28, 2024, the total number of issued shares of common stock is 86,126,221 of which 81,373,679 shares are outstanding.  Autoliv retired 1,370,057...

at 06:15
Euna Solutions®, a leading provider of purpose-built, cloud-based solutions for the public sector, today announced the launch of Euna Budget: Strategic Budgeting, a first-of-its-kind offering that enables city leaders to connect their strategic plans...

at 06:11
OKX, a global leading Web3 technology company and crypto exchange, has opened entries for its Bitcoin halving-themed 'The Ultimate Bitcoin Rush' and 'OKX Web3 Bitcoin Drop' trading campaigns, featuring a prize pool worth over 10 BTC....

at 06:10
Confo Therapeutics, a leader in the discovery of novel medicines targeting G-protein coupled receptors (GPCRs), announced today that it has been awarded a EUR 1.6 million grant from Flanders Innovation & Entrepreneurship (VLAIO). The 2-year grant...

at 06:05
The 2023 U.S. soybean field trials conducted by Texas Crop Science (TCS) demonstrated an average yield increase of 21% in soybean lines incorporating the TCS yield trait. This breakthrough in performance would generate approximately $121 per acre in...

at 06:05
3EO Health, a "Point of Life" diagnostics company focused on the development of high-performing low-cost molecular diagnostics, is excited to announce the next step in their quest to make molecular testing affordable. Today, the company has published...



News published on and distributed by: